Indian drugmaker Cipla Limited has entered into a strategic marketing and distribution agreement with US pharma major Eli ...
The company is banking on key new launches, including weight loss drug Semaglutide and biosimilar Abatacept to drive growth ...
Eli Lilly and Co. has reached an agreement with pharmaceutical Cipla to market tirzepatide, the active ingredient in Lilly’s ...
Dr Reddy's Laboratories has received approval to manufacture and market generic semaglutide, a weight loss drug, once Novo Nordisk's patent expires in 2026.
Britain's Medicines and Healthcare products Regulatory Agency seized a large cache of unlicensed weight-loss drugs, including ...
Khaleej Times on MSN
UK makes world's largest seizure of unlicensed weight-loss drugs in factory raid
They have dismantled a factory that made injections labelled as containing tirzepatide, the ingredient in Eli Lilly's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback